Search
ChatPaper
AI Writing
analysis
Analysis
编组
Open Data
more
More
RankingsMust ReadingJournal&ConferenceAI TRAI HistoryMaster Reading TreeXiaomai's Star TalentsTrajectoryTalentNDI TrackerAI sign LanguageOpen
VIPCreated with Sketch.

Effectiveness of two and three mRNA COVID-19 vaccine doses against Omicron- and Delta-Related outpatient illness among adults, October 2021-February 2022.

Sara S. Kim,Jessie R. Chung,H. Keipp Talbot,Carlos G. Grijalva,Karen J. Wernli,Erika Kiniry,Emily T. Martin,Arnold S. Monto,Edward A. Belongia,Huong Q. McLean,Manjusha Gaglani,Mufaddal Mamawala,Mary Patricia Nowalk,Krissy Moehling Geffel,Sara Y. Tartof,Ana Florea,Justin S. Lee,Mark W. Tenforde,Manish M. Patel,Brendan Flannery,Meghan L. Bentz, Alex Burgin,Mark Burroughs,Morgan L. Davis,Dakota Howard,Kristine Lacek, Joseph C. Madden,Sarah Nobles,Jasmine Padilla,Mili Sheth

Influenza and other respiratory viruses（2022）

Cited 10|Views10
No score
Abstract
In this adult population, three mRNA COVID-19 vaccine doses provided substantial protection against symptomatic illness in outpatient settings when the Omicron variant became the predominant cause of COVID-19 in the United States. These findings support the recommendation for a third mRNA COVID-19 vaccine dose.
More
Translated text
Key words
COVID‐19,outpatient,vaccine effectiveness
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined